Currently, 10 months after LV resynchronization and heart failure therapy, he is doing well without signs of heart failure with an EF of 54%, LV GLS of −13.9%, normalized LVEDD, and a further decreased NT-proBNP level to 758 ng/L (see Supplementary material online, Video S3). This evidence concerns the gene NPPB and heart failure.